Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina
Levels of primary resistance in Buenos Aires are still low, despite a long history of ARV delivery and high coverage levels, and evidence for the transmission of the K103N mutation among the drug-naive population is revealed. Expand
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina
The poor outcome of patients with HIV/TB in Eastern Europe deserves further study and urgent public health attention. Expand
[Sexually transmitted infections among transgender individuals and other sexual identities].
The data show that this population has a very high prevalence of HIV-1 and STI, and this information could be instrumental to design targets for intensive HIV prevention strategies in this particular high risk population. Expand
Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America
Improved management of TB/HIV patients in EE requires better access to TB diagnostics including DSTs, empiric anti-TB therapy directed at both susceptible and MDR-TB, and more widespread use of cART. Expand
[HIV patient hospitalization during the pre and post-HAART era].
The purpose of this study was to describe and to compare the characteristics of patient admissions during two periods, one pre HAART and the other when HAART was fully available, to find significant differences in the causes of admission and outcome. Expand
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
Patients with HIV and tuberculosis in eastern Europe have a risk of death nearly four times higher than that in patients from western Europe and Latin America, and this increased mortality rate is associated with modifiable risk factors such as lack of drug susceptibility testing and suboptimal initial antituberculosis treatment in settings with a high prevalence of drug resistance. Expand
The Use of Saquinavir/Ritonavir 1000/100 Mg Twice Daily in Patients with Tuberculosis Receiving Rifampin
A retrospective safety and efficacy analysis of two ARV regimens in HIV-infected patients receiving rifampin for TB is carried out by reviewing the clinical charts of patients undergoing concomitant treatment for TB and HIV at an ambulatory HIV clinic. Expand
The role of brain biopsy in the clinical management of HIV‐related focal brain lesions
The clinical outcomes of patients with FBL, the proportion of diagnoses confirmed by brain biopsies and their aetiologies, and theportion of patients in whom the biopsy motivated a change in therapeutic management are described are described. Expand
One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America
Despite comparable use of recommended anti-TB treatment, mortality of patients with rifampicin/isoniazid-susceptible TB remained higher in Eastern Europe when compared with Western Europe/Latin America. Expand
Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America
- A. Efsen, A. Schultze, +15 authors O. Kirk
- Journal of the International AIDS Society
- 1 November 2014
The aim was to study the clinical characteristics of TB/HIV patients in Europe and Latin America at TB diagnosis, identify factors associated with MDR‐TB and assess the activity of initial TB treatment regimens given the results of drug‐susceptibility tests (DST). Expand